Obsessive-Compulsive Disorder (OCD) Global Clinical Trials Review 2024: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
April 25, 2024 10:19 ET
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The...
Promising perspectives for the application of SDS Optic’s inPROBE technology platform for protein expression determination
April 25, 2024 08:00 ET
|
SDS Optic S.A.
SDS Optic's positive results from the Part I Clinical Trial of the novel optic fiber probe, inPROBE®, in vivo real-time molecular diagnostic technology.
Glaucoma Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Points Status
April 24, 2024 08:38 ET
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Glaucoma - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report,...
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
April 23, 2024 13:42 ET
|
Novartis Pharma AG
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and adult patients Gastroenteropancreatic...
Lennox-Gastaut Syndrome Global Clinical Trials Review 2024: Phase, Trial Status, End Points Status and Sponsor Type
April 23, 2024 10:42 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment
April 17, 2024 08:00 ET
|
Science 37, Inc.
Science 37's Patient Recruitment Solution provides fully-consented patients to clinical trial sites to supplement enrollment.
Cutaneous Squamous Cell Carcinoma (CSCC) Global Clinical Trials Review 2024: Trial Status, Trial Phase, Sponsor Type, End Point Status, Country (G7 & E7)
April 08, 2024 09:31 ET
|
Research and Markets
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "Cutaneous Squamous Cell Carcinoma (Cscc) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
Idiopathic Pulmonary Fibrosis Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End-Point Status
April 08, 2024 09:20 ET
|
Research and Markets
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report...
Seasonal Influenza Global Clinical Trials Review 2024 Featuring GSK, Novartis, Johnson & Johnson, Novavax, CSL, Sinovac Biotech, Moderna, and Sanofi, Among Others
April 05, 2024 09:29 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Seasonal Influenza - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
H1 Launches New Solution Empowering Doctors to Find Global Health Opportunities
April 04, 2024 12:00 ET
|
H1
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- H1, the leading platform for global healthcare data with a database of 10M+ healthcare professional profiles, today announced a new module within its H1...